The board of Marksans Pharma has decided to make allotment of 8400241 equity shares of Re 1 to Bamacle LLC on preferential allotment basis.
This was decided at the board meeting held on 23 September 2008.
BSE tips
CafeStocks Search Engine - Enter any stock market related word to search
Custom Search
Tuesday, September 23, 2008
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment